Repository logoGCRIS
  • English
  • Türkçe
  • Русский
Log In
New user? Click here to register. Have you forgotten your password?
Home
Communities
Browse GCRIS
Overview
GCRIS Guide
  1. Home
  2. Browse by Author

Browsing by Author "Odabasi, D."

Filter results by typing the first few letters
Now showing 1 - 5 of 5
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Article
    Antioxidant and Renoprotective Effects of Paricalcitol on Experimental Contrast-Induced Nephropathy Model
    (British inst Radiology, 2012) Ari, E.; Kedrah, A. E.; Alahdab, Y.; Bulut, G.; Eren, Z.; Baytekin, O.; Odabasi, D.
    Objectives: The aim of the study was to assess the effect of paricalcitol on the experimental contrast-induced nephropathy (CIN) model. We hypothesised that paricalcitol may prevent CIN. Methods: 32 Wistar albino rats were divided into four groups (n=8 each): control group, paricalcitol group, CIN group and paricalcitol plus CIN group. Paricalcitol (0.4 mu g kg(-1) day(-1)) was given intraperitoneally for 5 consecutive days prior to induction of CIN. CIN was induced at day 4 by intravenous injection of indometacin (10 mg kg(-1)), N omega-nitro-L-arginine methyl ester (L-NAME, 10 mg kg(-1)) and meglumine amidotrizoate (6 ml kg(-1)). Renal function parameters, oxidative stress biomarkers, histopathological findings and vascular endothelial growth factor (VEGF) immunoexpression were evaluated. Results: The paricalcitol plus CIN group had lower mean serum creatinine levels (p=0.034) as well as higher creatinine clearance (p=0.042) than the CIN group. Serum malondialdehyde and kidney thiobarbituric acid-reacting substances levels were significantly lower in the paricalcitol plus CIN group than in the CIN group (p=0.024 and p=0.042, respectively). The mean scores of tubular necrosis (p=0.024), proteinaceous casts (p=0.038), medullary congestion (p=0.035) and VEGF immunoexpression (p=0.018) in the paricalcitol plus CIN group were also significantly lower. Conclusion: This study demonstrates the protective effect of paricalcitol in the prevention of CIN in an experimental model.
  • Loading...
    Thumbnail Image
    Conference Object
    Arterio-Venous Fistula Management With Saphenous Vein Graft Interposition in Hemodialysis Patients; Clinical Study; Mid-Term Results
    (Elsevier Ireland Ltd, 2011) Odabasi, D.; Basel, H.; Ekim, H.
  • Loading...
    Thumbnail Image
    Conference Object
    Management of Constrictive Pericarditis: A Comparative Study Between Median Sternotomy and Left Thoracotomy
    (Elsevier Ireland Ltd, 2011) Ekim, H.; Odabasi, D.; Basel, H.
  • Loading...
    Thumbnail Image
    Conference Object
    Management of Penetrating Heart and Accompanying Lung Injuries
    (Elsevier Ireland Ltd, 2011) Ekim, H.; Odabasi, D.; Basel, H.
  • Loading...
    Thumbnail Image
    Conference Object
    Movable Thrombus Attached on Mitral Anterior Leaflet
    (Elsevier Ireland Ltd, 2011) Gumrukcuoglu, H. A.; Odabasi, D.; Ekim, H.; Akdag, S.; Ozdemir, M.
Repository logo
Collections
  • Scopus Collection
  • WoS Collection
  • TrDizin Collection
  • PubMed Collection
About
  • Contact
  • GCRIS
  • Research Ecosystems
  • Feedback
  • OAI-PMH

Powered by Research Ecosystems

  • Privacy policy
  • End User Agreement
  • Feedback